Should You Accumulate Reneo Pharmaceuticals Inc (RPHM) Stock Thursday Morning?

Reneo Pharmaceuticals Inc (RPHM) has fallen Thursday morning, with the stock decreasing -1.82% in pre-market trading to 1.62. RPHM's short-term technical score of 12 indicates that the stock has traded less bullishly over the last month than 88% of stocks on the market. In the Biotechnology industry, which ranks 116 out of 146 industries, Reneo Pharmaceuticals Inc ranks higher than 23% of stocks. Reneo Pharmaceuticals Inc has fallen 77.24% over the past month, closing at $7.00 on December 7. During this period of time, the stock fell as low as $1.34 and as high as $7.76. RPHM has an average analyst recommendation of Sell. The company has an average price target of $2.12.

RPHM has an Overall Score of 20. Find out what this means to you and get the rest of the rankings on RPHM!

See Full RPHM Report

Reneo Pharmaceuticals Inc has a Long-Term Technical rank of 1. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 99% of the market scoring higher. In the Biotechnology industry which is number 100 by this metric, RPHM ranks better than 100% of stocks.

Important Dates for Investors in RPHM:

-Reneo Pharmaceuticals Inc is set to release earnings on 2024-02-11. Over the last 12 months, the company has reported EPS of $-2.38. -We do not have a set dividend date for Reneo Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Reneo Pharmaceuticals Inc (RPHM)